nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—Thiotepa—sarcoma	0.326	0.458	CbGbCtD
Flucloxacillin—CYP3A4—Mitoxantrone—sarcoma	0.14	0.197	CbGbCtD
Flucloxacillin—CYP3A4—Vincristine—sarcoma	0.0965	0.136	CbGbCtD
Flucloxacillin—CYP3A4—Etoposide—sarcoma	0.0884	0.124	CbGbCtD
Flucloxacillin—CYP3A4—Doxorubicin—sarcoma	0.0603	0.0848	CbGbCtD
Flucloxacillin—Connective tissue disorder—Thiotepa—sarcoma	0.0019	0.00659	CcSEcCtD
Flucloxacillin—Urethral disorder—Thiotepa—sarcoma	0.00189	0.00657	CcSEcCtD
Flucloxacillin—Renal failure—Mitoxantrone—sarcoma	0.00183	0.00634	CcSEcCtD
Flucloxacillin—Erythema multiforme—Dactinomycin—sarcoma	0.00181	0.00629	CcSEcCtD
Flucloxacillin—Jaundice—Mitoxantrone—sarcoma	0.00181	0.00629	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00181	0.00627	CcSEcCtD
Flucloxacillin—Haematuria—Mitoxantrone—sarcoma	0.00177	0.00615	CcSEcCtD
Flucloxacillin—Jaundice cholestatic—Epirubicin—sarcoma	0.00176	0.00612	CcSEcCtD
Flucloxacillin—Immune system disorder—Thiotepa—sarcoma	0.00175	0.00606	CcSEcCtD
Flucloxacillin—Agranulocytosis—Mitoxantrone—sarcoma	0.00174	0.00602	CcSEcCtD
Flucloxacillin—Bronchospasm—Etoposide—sarcoma	0.00171	0.00592	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Vincristine—sarcoma	0.00169	0.00587	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Vincristine—sarcoma	0.00168	0.00584	CcSEcCtD
Flucloxacillin—Urethral disorder—Vincristine—sarcoma	0.00168	0.00583	CcSEcCtD
Flucloxacillin—Hepatitis—Mitoxantrone—sarcoma	0.00167	0.00579	CcSEcCtD
Flucloxacillin—Jaundice cholestatic—Doxorubicin—sarcoma	0.00163	0.00566	CcSEcCtD
Flucloxacillin—Neutropenia—Etoposide—sarcoma	0.00162	0.00563	CcSEcCtD
Flucloxacillin—Anaemia—Thiotepa—sarcoma	0.00156	0.00539	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Dactinomycin—sarcoma	0.00155	0.00537	CcSEcCtD
Flucloxacillin—Anaemia—Dactinomycin—sarcoma	0.00154	0.00535	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00153	0.00532	CcSEcCtD
Flucloxacillin—Renal failure—Etoposide—sarcoma	0.00152	0.00527	CcSEcCtD
Flucloxacillin—Jaundice—Etoposide—sarcoma	0.00151	0.00523	CcSEcCtD
Flucloxacillin—Leukopenia—Thiotepa—sarcoma	0.00151	0.00522	CcSEcCtD
Flucloxacillin—Malaise—Dactinomycin—sarcoma	0.00151	0.00522	CcSEcCtD
Flucloxacillin—Leukopenia—Dactinomycin—sarcoma	0.00149	0.00518	CcSEcCtD
Flucloxacillin—Colitis—Epirubicin—sarcoma	0.00149	0.00516	CcSEcCtD
Flucloxacillin—Candida infection—Epirubicin—sarcoma	0.00148	0.00513	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Etoposide—sarcoma	0.00146	0.00507	CcSEcCtD
Flucloxacillin—Convulsion—Thiotepa—sarcoma	0.00146	0.00506	CcSEcCtD
Flucloxacillin—Agranulocytosis—Etoposide—sarcoma	0.00144	0.00501	CcSEcCtD
Flucloxacillin—Arthralgia—Thiotepa—sarcoma	0.00143	0.00497	CcSEcCtD
Flucloxacillin—Myalgia—Thiotepa—sarcoma	0.00143	0.00497	CcSEcCtD
Flucloxacillin—Dysgeusia—Mitoxantrone—sarcoma	0.00142	0.00494	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00142	0.00493	CcSEcCtD
Flucloxacillin—Myalgia—Dactinomycin—sarcoma	0.00142	0.00493	CcSEcCtD
Flucloxacillin—Discomfort—Dactinomycin—sarcoma	0.0014	0.00487	CcSEcCtD
Flucloxacillin—Anaemia—Vincristine—sarcoma	0.00138	0.00478	CcSEcCtD
Flucloxacillin—Colitis—Doxorubicin—sarcoma	0.00138	0.00478	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Etoposide—sarcoma	0.00137	0.00476	CcSEcCtD
Flucloxacillin—Candida infection—Doxorubicin—sarcoma	0.00137	0.00475	CcSEcCtD
Flucloxacillin—Urethral disorder—Etoposide—sarcoma	0.00136	0.00472	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Mitoxantrone—sarcoma	0.00135	0.00468	CcSEcCtD
Flucloxacillin—Nervous system disorder—Thiotepa—sarcoma	0.00135	0.00467	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Thiotepa—sarcoma	0.00134	0.00466	CcSEcCtD
Flucloxacillin—Anaemia—Mitoxantrone—sarcoma	0.00134	0.00466	CcSEcCtD
Flucloxacillin—Leukopenia—Vincristine—sarcoma	0.00134	0.00463	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Dactinomycin—sarcoma	0.00133	0.00463	CcSEcCtD
Flucloxacillin—Skin disorder—Thiotepa—sarcoma	0.00133	0.00463	CcSEcCtD
Flucloxacillin—Erythema multiforme—Etoposide—sarcoma	0.00131	0.00455	CcSEcCtD
Flucloxacillin—Malaise—Mitoxantrone—sarcoma	0.00131	0.00454	CcSEcCtD
Flucloxacillin—Leukopenia—Mitoxantrone—sarcoma	0.0013	0.00451	CcSEcCtD
Flucloxacillin—Convulsion—Vincristine—sarcoma	0.00129	0.00448	CcSEcCtD
Flucloxacillin—Myalgia—Vincristine—sarcoma	0.00127	0.00441	CcSEcCtD
Flucloxacillin—Convulsion—Mitoxantrone—sarcoma	0.00126	0.00437	CcSEcCtD
Flucloxacillin—Vascular purpura—Epirubicin—sarcoma	0.00126	0.00436	CcSEcCtD
Flucloxacillin—Immune system disorder—Etoposide—sarcoma	0.00125	0.00435	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00125	0.00434	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00124	0.00431	CcSEcCtD
Flucloxacillin—Arthralgia—Mitoxantrone—sarcoma	0.00124	0.00429	CcSEcCtD
Flucloxacillin—Myalgia—Mitoxantrone—sarcoma	0.00124	0.00429	CcSEcCtD
Flucloxacillin—Discomfort—Mitoxantrone—sarcoma	0.00122	0.00424	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Vincristine—sarcoma	0.00122	0.00422	CcSEcCtD
Flucloxacillin—Dyspepsia—Thiotepa—sarcoma	0.00121	0.00419	CcSEcCtD
Flucloxacillin—Nervous system disorder—Vincristine—sarcoma	0.00119	0.00414	CcSEcCtD
Flucloxacillin—Decreased appetite—Thiotepa—sarcoma	0.00119	0.00414	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Vincristine—sarcoma	0.00119	0.00414	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Mitoxantrone—sarcoma	0.00119	0.00411	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Thiotepa—sarcoma	0.00119	0.00411	CcSEcCtD
Flucloxacillin—Decreased appetite—Dactinomycin—sarcoma	0.00118	0.00411	CcSEcCtD
Flucloxacillin—Dysgeusia—Etoposide—sarcoma	0.00118	0.00411	CcSEcCtD
Flucloxacillin—Constipation—Thiotepa—sarcoma	0.00117	0.00407	CcSEcCtD
Flucloxacillin—Purpura—Epirubicin—sarcoma	0.00117	0.00405	CcSEcCtD
Flucloxacillin—Vascular purpura—Doxorubicin—sarcoma	0.00116	0.00404	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Mitoxantrone—sarcoma	0.00116	0.00403	CcSEcCtD
Flucloxacillin—Skin disorder—Mitoxantrone—sarcoma	0.00115	0.004	CcSEcCtD
Flucloxacillin—Feeling abnormal—Thiotepa—sarcoma	0.00113	0.00392	CcSEcCtD
Flucloxacillin—Feeling abnormal—Dactinomycin—sarcoma	0.00112	0.0039	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Thiotepa—sarcoma	0.00112	0.00389	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Etoposide—sarcoma	0.00112	0.00389	CcSEcCtD
Flucloxacillin—Anaemia—Etoposide—sarcoma	0.00112	0.00387	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Dactinomycin—sarcoma	0.00111	0.00387	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Vincristine—sarcoma	0.00111	0.00385	CcSEcCtD
Flucloxacillin—Urticaria—Thiotepa—sarcoma	0.00109	0.00378	CcSEcCtD
Flucloxacillin—Malaise—Etoposide—sarcoma	0.00109	0.00378	CcSEcCtD
Flucloxacillin—Body temperature increased—Thiotepa—sarcoma	0.00109	0.00377	CcSEcCtD
Flucloxacillin—Abdominal pain—Thiotepa—sarcoma	0.00109	0.00377	CcSEcCtD
Flucloxacillin—Leukopenia—Etoposide—sarcoma	0.00108	0.00375	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00108	0.00375	CcSEcCtD
Flucloxacillin—Purpura—Doxorubicin—sarcoma	0.00108	0.00375	CcSEcCtD
Flucloxacillin—Body temperature increased—Dactinomycin—sarcoma	0.00108	0.00374	CcSEcCtD
Flucloxacillin—Abdominal pain—Dactinomycin—sarcoma	0.00108	0.00374	CcSEcCtD
Flucloxacillin—Decreased appetite—Vincristine—sarcoma	0.00106	0.00367	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Vincristine—sarcoma	0.00105	0.00365	CcSEcCtD
Flucloxacillin—Convulsion—Etoposide—sarcoma	0.00105	0.00363	CcSEcCtD
Flucloxacillin—Dyspepsia—Mitoxantrone—sarcoma	0.00104	0.00362	CcSEcCtD
Flucloxacillin—Constipation—Vincristine—sarcoma	0.00104	0.00361	CcSEcCtD
Flucloxacillin—Decreased appetite—Mitoxantrone—sarcoma	0.00103	0.00358	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00102	0.00354	CcSEcCtD
Flucloxacillin—Discomfort—Etoposide—sarcoma	0.00102	0.00353	CcSEcCtD
Flucloxacillin—Constipation—Mitoxantrone—sarcoma	0.00101	0.00352	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00101	0.00351	CcSEcCtD
Flucloxacillin—Hypersensitivity—Thiotepa—sarcoma	0.00101	0.00351	CcSEcCtD
Flucloxacillin—Hypersensitivity—Dactinomycin—sarcoma	0.001	0.00348	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Vincristine—sarcoma	0.000996	0.00345	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Etoposide—sarcoma	0.000986	0.00342	CcSEcCtD
Flucloxacillin—Feeling abnormal—Mitoxantrone—sarcoma	0.000977	0.00339	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00097	0.00336	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Etoposide—sarcoma	0.000966	0.00335	CcSEcCtD
Flucloxacillin—Eosinophilia—Epirubicin—sarcoma	0.000963	0.00334	CcSEcCtD
Flucloxacillin—Body temperature increased—Vincristine—sarcoma	0.000963	0.00334	CcSEcCtD
Flucloxacillin—Abdominal pain—Vincristine—sarcoma	0.000963	0.00334	CcSEcCtD
Flucloxacillin—Skin disorder—Etoposide—sarcoma	0.000958	0.00332	CcSEcCtD
Flucloxacillin—Urticaria—Mitoxantrone—sarcoma	0.000942	0.00327	CcSEcCtD
Flucloxacillin—Diarrhoea—Thiotepa—sarcoma	0.000939	0.00326	CcSEcCtD
Flucloxacillin—Abdominal pain—Mitoxantrone—sarcoma	0.000937	0.00325	CcSEcCtD
Flucloxacillin—Body temperature increased—Mitoxantrone—sarcoma	0.000937	0.00325	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000937	0.00325	CcSEcCtD
Flucloxacillin—Diarrhoea—Dactinomycin—sarcoma	0.000932	0.00323	CcSEcCtD
Flucloxacillin—Neutropenia—Epirubicin—sarcoma	0.000909	0.00315	CcSEcCtD
Flucloxacillin—Dizziness—Thiotepa—sarcoma	0.000908	0.00315	CcSEcCtD
Flucloxacillin—Hypersensitivity—Vincristine—sarcoma	0.000897	0.00311	CcSEcCtD
Flucloxacillin—Eosinophilia—Doxorubicin—sarcoma	0.000891	0.00309	CcSEcCtD
Flucloxacillin—Hypersensitivity—Mitoxantrone—sarcoma	0.000874	0.00303	CcSEcCtD
Flucloxacillin—Vomiting—Thiotepa—sarcoma	0.000873	0.00303	CcSEcCtD
Flucloxacillin—Vomiting—Dactinomycin—sarcoma	0.000866	0.00301	CcSEcCtD
Flucloxacillin—Rash—Thiotepa—sarcoma	0.000866	0.003	CcSEcCtD
Flucloxacillin—Dermatitis—Thiotepa—sarcoma	0.000865	0.003	CcSEcCtD
Flucloxacillin—Headache—Thiotepa—sarcoma	0.00086	0.00298	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000859	0.00298	CcSEcCtD
Flucloxacillin—Rash—Dactinomycin—sarcoma	0.000859	0.00298	CcSEcCtD
Flucloxacillin—Decreased appetite—Etoposide—sarcoma	0.000857	0.00297	CcSEcCtD
Flucloxacillin—Renal failure—Epirubicin—sarcoma	0.000852	0.00296	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Etoposide—sarcoma	0.000852	0.00295	CcSEcCtD
Flucloxacillin—Jaundice—Epirubicin—sarcoma	0.000845	0.00293	CcSEcCtD
Flucloxacillin—Constipation—Etoposide—sarcoma	0.000843	0.00293	CcSEcCtD
Flucloxacillin—Neutropenia—Doxorubicin—sarcoma	0.000841	0.00292	CcSEcCtD
Flucloxacillin—Diarrhoea—Vincristine—sarcoma	0.000833	0.00289	CcSEcCtD
Flucloxacillin—Haematuria—Epirubicin—sarcoma	0.000827	0.00287	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Epirubicin—sarcoma	0.00082	0.00284	CcSEcCtD
Flucloxacillin—Nausea—Thiotepa—sarcoma	0.000816	0.00283	CcSEcCtD
Flucloxacillin—Feeling abnormal—Etoposide—sarcoma	0.000813	0.00282	CcSEcCtD
Flucloxacillin—Diarrhoea—Mitoxantrone—sarcoma	0.000811	0.00281	CcSEcCtD
Flucloxacillin—Nausea—Dactinomycin—sarcoma	0.000809	0.00281	CcSEcCtD
Flucloxacillin—Agranulocytosis—Epirubicin—sarcoma	0.000809	0.00281	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Etoposide—sarcoma	0.000807	0.0028	CcSEcCtD
Flucloxacillin—Dizziness—Vincristine—sarcoma	0.000805	0.00279	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000795	0.00276	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—sarcoma	0.000788	0.00273	CcSEcCtD
Flucloxacillin—Urticaria—Etoposide—sarcoma	0.000784	0.00272	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—sarcoma	0.000782	0.00271	CcSEcCtD
Flucloxacillin—Body temperature increased—Etoposide—sarcoma	0.00078	0.0027	CcSEcCtD
Flucloxacillin—Abdominal pain—Etoposide—sarcoma	0.00078	0.0027	CcSEcCtD
Flucloxacillin—Hepatitis—Epirubicin—sarcoma	0.000778	0.0027	CcSEcCtD
Flucloxacillin—Vomiting—Vincristine—sarcoma	0.000774	0.00269	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Epirubicin—sarcoma	0.000769	0.00267	CcSEcCtD
Flucloxacillin—Rash—Vincristine—sarcoma	0.000768	0.00266	CcSEcCtD
Flucloxacillin—Dermatitis—Vincristine—sarcoma	0.000767	0.00266	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—sarcoma	0.000765	0.00265	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Epirubicin—sarcoma	0.000765	0.00265	CcSEcCtD
Flucloxacillin—Urethral disorder—Epirubicin—sarcoma	0.000763	0.00265	CcSEcCtD
Flucloxacillin—Headache—Vincristine—sarcoma	0.000763	0.00265	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000759	0.00263	CcSEcCtD
Flucloxacillin—Vomiting—Mitoxantrone—sarcoma	0.000754	0.00262	CcSEcCtD
Flucloxacillin—Agranulocytosis—Doxorubicin—sarcoma	0.000749	0.0026	CcSEcCtD
Flucloxacillin—Rash—Mitoxantrone—sarcoma	0.000748	0.00259	CcSEcCtD
Flucloxacillin—Dermatitis—Mitoxantrone—sarcoma	0.000747	0.00259	CcSEcCtD
Flucloxacillin—Headache—Mitoxantrone—sarcoma	0.000743	0.00258	CcSEcCtD
Flucloxacillin—Erythema multiforme—Epirubicin—sarcoma	0.000736	0.00255	CcSEcCtD
Flucloxacillin—Hypersensitivity—Etoposide—sarcoma	0.000727	0.00252	CcSEcCtD
Flucloxacillin—Nausea—Vincristine—sarcoma	0.000723	0.00251	CcSEcCtD
Flucloxacillin—Hepatitis—Doxorubicin—sarcoma	0.00072	0.0025	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Doxorubicin—sarcoma	0.000711	0.00247	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—sarcoma	0.000708	0.00245	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—sarcoma	0.000706	0.00245	CcSEcCtD
Flucloxacillin—Nausea—Mitoxantrone—sarcoma	0.000704	0.00244	CcSEcCtD
Flucloxacillin—Immune system disorder—Epirubicin—sarcoma	0.000703	0.00244	CcSEcCtD
Flucloxacillin—Erythema multiforme—Doxorubicin—sarcoma	0.000681	0.00236	CcSEcCtD
Flucloxacillin—Diarrhoea—Etoposide—sarcoma	0.000675	0.00234	CcSEcCtD
Flucloxacillin—Dysgeusia—Epirubicin—sarcoma	0.000663	0.0023	CcSEcCtD
Flucloxacillin—Dizziness—Etoposide—sarcoma	0.000652	0.00226	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—sarcoma	0.00065	0.00226	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Epirubicin—sarcoma	0.000629	0.00218	CcSEcCtD
Flucloxacillin—Vomiting—Etoposide—sarcoma	0.000627	0.00218	CcSEcCtD
Flucloxacillin—Anaemia—Epirubicin—sarcoma	0.000626	0.00217	CcSEcCtD
Flucloxacillin—Rash—Etoposide—sarcoma	0.000622	0.00216	CcSEcCtD
Flucloxacillin—Dermatitis—Etoposide—sarcoma	0.000621	0.00216	CcSEcCtD
Flucloxacillin—Headache—Etoposide—sarcoma	0.000618	0.00214	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—sarcoma	0.000614	0.00213	CcSEcCtD
Flucloxacillin—Malaise—Epirubicin—sarcoma	0.000611	0.00212	CcSEcCtD
Flucloxacillin—Leukopenia—Epirubicin—sarcoma	0.000606	0.0021	CcSEcCtD
Flucloxacillin—Convulsion—Epirubicin—sarcoma	0.000587	0.00204	CcSEcCtD
Flucloxacillin—Nausea—Etoposide—sarcoma	0.000586	0.00203	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—sarcoma	0.000582	0.00202	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—sarcoma	0.000579	0.00201	CcSEcCtD
Flucloxacillin—Arthralgia—Epirubicin—sarcoma	0.000577	0.002	CcSEcCtD
Flucloxacillin—Myalgia—Epirubicin—sarcoma	0.000577	0.002	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000573	0.00199	CcSEcCtD
Flucloxacillin—Discomfort—Epirubicin—sarcoma	0.00057	0.00198	CcSEcCtD
Flucloxacillin—Malaise—Doxorubicin—sarcoma	0.000565	0.00196	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—sarcoma	0.000561	0.00195	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Epirubicin—sarcoma	0.000553	0.00192	CcSEcCtD
Flucloxacillin—Convulsion—Doxorubicin—sarcoma	0.000543	0.00188	CcSEcCtD
Flucloxacillin—Nervous system disorder—Epirubicin—sarcoma	0.000542	0.00188	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Epirubicin—sarcoma	0.000541	0.00188	CcSEcCtD
Flucloxacillin—Skin disorder—Epirubicin—sarcoma	0.000537	0.00186	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—sarcoma	0.000534	0.00185	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—sarcoma	0.000534	0.00185	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00053	0.00184	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—sarcoma	0.000527	0.00183	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—sarcoma	0.000512	0.00177	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000504	0.00175	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—sarcoma	0.000502	0.00174	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—sarcoma	0.000501	0.00174	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—sarcoma	0.000497	0.00172	CcSEcCtD
Flucloxacillin—Dyspepsia—Epirubicin—sarcoma	0.000487	0.00169	CcSEcCtD
Flucloxacillin—Decreased appetite—Epirubicin—sarcoma	0.000481	0.00167	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000477	0.00166	CcSEcCtD
Flucloxacillin—Constipation—Epirubicin—sarcoma	0.000473	0.00164	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000466	0.00162	CcSEcCtD
Flucloxacillin—Feeling abnormal—Epirubicin—sarcoma	0.000456	0.00158	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Epirubicin—sarcoma	0.000452	0.00157	CcSEcCtD
Flucloxacillin—Dyspepsia—Doxorubicin—sarcoma	0.00045	0.00156	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—sarcoma	0.000445	0.00154	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000442	0.00153	CcSEcCtD
Flucloxacillin—Urticaria—Epirubicin—sarcoma	0.000439	0.00152	CcSEcCtD
Flucloxacillin—Constipation—Doxorubicin—sarcoma	0.000437	0.00152	CcSEcCtD
Flucloxacillin—Abdominal pain—Epirubicin—sarcoma	0.000437	0.00152	CcSEcCtD
Flucloxacillin—Body temperature increased—Epirubicin—sarcoma	0.000437	0.00152	CcSEcCtD
Flucloxacillin—Feeling abnormal—Doxorubicin—sarcoma	0.000422	0.00146	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000418	0.00145	CcSEcCtD
Flucloxacillin—Hypersensitivity—Epirubicin—sarcoma	0.000407	0.00141	CcSEcCtD
Flucloxacillin—Urticaria—Doxorubicin—sarcoma	0.000406	0.00141	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—sarcoma	0.000404	0.0014	CcSEcCtD
Flucloxacillin—Abdominal pain—Doxorubicin—sarcoma	0.000404	0.0014	CcSEcCtD
Flucloxacillin—Diarrhoea—Epirubicin—sarcoma	0.000378	0.00131	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—sarcoma	0.000377	0.00131	CcSEcCtD
Flucloxacillin—Dizziness—Epirubicin—sarcoma	0.000366	0.00127	CcSEcCtD
Flucloxacillin—Vomiting—Epirubicin—sarcoma	0.000352	0.00122	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—sarcoma	0.00035	0.00121	CcSEcCtD
Flucloxacillin—Rash—Epirubicin—sarcoma	0.000349	0.00121	CcSEcCtD
Flucloxacillin—Dermatitis—Epirubicin—sarcoma	0.000348	0.00121	CcSEcCtD
Flucloxacillin—Headache—Epirubicin—sarcoma	0.000346	0.0012	CcSEcCtD
Flucloxacillin—Dizziness—Doxorubicin—sarcoma	0.000338	0.00117	CcSEcCtD
Flucloxacillin—Nausea—Epirubicin—sarcoma	0.000328	0.00114	CcSEcCtD
Flucloxacillin—Vomiting—Doxorubicin—sarcoma	0.000325	0.00113	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—sarcoma	0.000323	0.00112	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—sarcoma	0.000322	0.00112	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—sarcoma	0.00032	0.00111	CcSEcCtD
Flucloxacillin—Nausea—Doxorubicin—sarcoma	0.000304	0.00105	CcSEcCtD
